We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





New Dipstick Technology Could Offer Faster, Cheaper and Mobile COVID-19 Diagnosis

By LabMedica International staff writers
Posted on 07 Oct 2020
Print article
Image: A simple dipstick allows genetic material to be extracted in as little as 30 seconds (Photo courtesy of University of Queensland)
Image: A simple dipstick allows genetic material to be extracted in as little as 30 seconds (Photo courtesy of University of Queensland)
A new technology that helps to quickly extract and analyze genetic material could be used for cheap, accurate and mobile COVID-19 testing, including at airports and remote testing centers.

‘Dipstick’ technology, developed by the University of Queensland (Queensland, Australia) allows genetic material to be extracted in as little as 30 seconds, with a full molecular diagnosis in 40 minutes. The process can be used to extract genetic material from most living organisms, including people, livestock, bacteria and viruses. The researchers have already applied the technology in other areas, primarily to fight plant pathogens. According to the team, their dipsticks can be produced quickly, cheaply and in bulk using a household pasta maker.

“Our dipstick tech is incredibly cheap and can be used virtually anywhere, without the need for specialized equipment or a laboratory,” said Professor Jimmy Botella of the University of Queensland. “Our tech enables the purification of DNA and RNA nucleic acids from patient samples - a critical step in COVID-19 diagnosis.”

“Combined with a portable diagnostic machine we’ve developed - which fits in your hand and can be powered by a car’s cigarette lighter connection - we could enable faster identification and isolation of positive patients, helping to reduce the spread of the disease,” added Botella. “We’re hoping it will be used to expand COVID-19 diagnostic testing to non-laboratory environments such as airports, remote testing centers and GP clinics.”

Related Links:
University of Queensland

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
SARS-CoV-2 Test
One Step SARS-CoV-2 Nucleic Acid Detection Kit (P761H)

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The utilization of liquid biopsies in cancer research is a rapidly developing field (Photo courtesy of Lightspring/Shutterstock)

Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis

B-cell lymphoma is the predominant form of cancer affecting the lymphatic system, with about 30% of patients with aggressive forms of this disease experiencing relapse. Currently, the disease’s risk assessment... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Sampler device could revolutionize sample collection for diagnostic tests (Photo courtesy of ReadyGo Diagnostics)

First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests

The COVID pandemic has dramatically reshaped the perception of diagnostics. Post the pandemic, a groundbreaking device that combines sample collection and processing into a single, easy-to-use disposable... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.